CVE-2025-61821: adobe coldfusion
Vulnerability summary
CVE-2025-61821 is a medium (CVSS 6.8) vulnerability in adobe coldfusion. EPSS estimates a 0.53% chance of exploitation in the next 30 days, higher than 43.5% of scored vulnerabilities.
Timeline
- 09-12-2025PublishedVulnerability first disclosed.
- 23-06-2026Last modifiedVulnerability information updated.
Description
ColdFusion versions 2025.4, 2023.16, 2021.22 and earlier are affected by an Improper Restriction of XML External Entity Reference ('XXE') vulnerability that could lead to arbitrary file system read. An attacker could exploit this vulnerability to access sensitive files and data on the server. Exploit depends on conditions beyond the attacker's control. Exploitation of this issue does not require user interaction and scope is changed.
CVSS metrics
2 scores · 2 sources · 1 version- NVDNIST6.8MediumCVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:C/C:H/I:N/A:N
EPSS trend
Probability
0.53%
Chance of exploitation in the next 30 days
Percentile
44%
Versus all other CVEs
30-day change
0.00 pp
From 0.53% on 20-09-2026
Known exploited
Compare KEV catalogsNot in any of the 3 tracked catalogs.
Public exploits
0 foundNo public exploits indexed.
Weaknesses
CWE · root causeAffected systems
Adobe1 product
- coldfusionEOL≤ 2021.22 | 2021 | 2021:update1 | 2021:update10 | 2021:update11 | 2021:update12 | 2021:update13 | 2021:update14 | 2021:update15 | 2021:update16 | 2021:update17 | 2021:update18 | 2021:update19 | 2021:update2 | 2021:update20 | 2021:update21 | 2021:update22 | 2021:update3 | 2021:update4 | 2021:update5 | 2021:update6 | 2021:update7 | 2021:update8 | 2021:update9 | 2023 | 2023:update1 | 2023:update10 | 2023:update11 | 2023:update12 | 2023:update13 | 2023:update14 | 2023:update15 | 2023:update16 | 2023:update2 | 2023:update3 | 2023:update4 | 2023:update5 | 2023:update6 | 2023:update7 | 2023:update8 | 2023:update9 | 2025 | 2025:update1 | 2025:update2 | 2025:update3 | 2025:update4
1 vendor · 1 product
References
1 links- helpx.adobe.com/security/products/coldfusion/apsb25-105.htmlVendor Advisory